These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12033517)

  • 1. Inhibition of human drug metabolizing cytochrome P450 by buprenorphine.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2002 May; 25(5):682-5. PubMed ID: 12033517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of gamma-oryzanol on cytochrome P450 activities in human liver microsomes.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2004 Jul; 27(7):1151-3. PubMed ID: 15256760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of probucol on cytochrome P450 activities in human liver microsomes.
    Umehara K; Shimokawa Y; Miyamoto G
    Biol Pharm Bull; 2002 Aug; 25(8):1112-4. PubMed ID: 12186421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes.
    Niwa T; Shiraga T; Hashimoto T; Kagayama A
    Biol Pharm Bull; 2004 Jan; 27(1):97-9. PubMed ID: 14709907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes.
    Wen X; Wang JS; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2002 Jan; 57(11):799-804. PubMed ID: 11868802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P-450 enzymes.
    Nakajima M; Ohyama K; Nakamura S; Shimada N; Yamazaki H; Yokoi T
    Drug Metab Dispos; 1999 Jul; 27(7):792-7. PubMed ID: 10383922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of buprenorphine and its metabolite norbuprenorphine with cytochromes p450 in vitro.
    Zhang W; Ramamoorthy Y; Tyndale RF; Sellers EM
    Drug Metab Dispos; 2003 Jun; 31(6):768-72. PubMed ID: 12756210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes.
    Niwa T; Shiraga T; Hashimoto T; Kagayama A
    Biol Pharm Bull; 2004 Mar; 27(3):415-7. PubMed ID: 14993813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions.
    Katoh M; Nakajima M; Shimada N; Yamazaki H; Yokoi T
    Eur J Clin Pharmacol; 2000; 55(11-12):843-52. PubMed ID: 10805063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.
    Bourrié M; Meunier V; Berger Y; Fabre G
    J Pharmacol Exp Ther; 1996 Apr; 277(1):321-32. PubMed ID: 8613937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds.
    Nakajima M; Suzuki M; Yamaji R; Takashina H; Shimada N; Yamazaki H; Yokoi T
    Xenobiotica; 1999 Dec; 29(12):1191-202. PubMed ID: 10647906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA; Tjia JF; Back DJ
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of irsogladine on P450-isoform specific activities in human hepatic microsomes.
    Nakamura A; Tougou K; Kitazumi H; Yamada T; Honjou K; Nonaka K; Mukai H
    Arzneimittelforschung; 2006; 56(7):547-52. PubMed ID: 16927538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory Effects of Dimethyllirioresinol, Epimagnolin A, Eudesmin, Fargesin, and Magnolin on Cytochrome P450 Enzyme Activities in Human Liver Microsomes.
    Kim JH; Kwon SS; Jeong HU; Lee HS
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No inhibition of cytochrome P450 activities in human liver microsomes by sulpiride, an antipsychotic drug.
    Niwa T; Inoue S; Shiraga T; Takagi A
    Biol Pharm Bull; 2005 Jan; 28(1):188-91. PubMed ID: 15635191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory Effects of Aschantin on Cytochrome P450 and Uridine 5'-diphospho-glucuronosyltransferase Enzyme Activities in Human Liver Microsomes.
    Kwon SS; Kim JH; Jeong HU; Cho YY; Oh SR; Lee HS
    Molecules; 2016 Apr; 21(5):. PubMed ID: 27128896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition screening of human hepatic P450 enzymes by five angiotensin-II receptor antagonists.
    Taavitsainen P; Kiukaanniemi K; Pelkonen O
    Eur J Clin Pharmacol; 2000 May; 56(2):135-40. PubMed ID: 10877007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of etodolac on P450 isoform-specific activities in human hepatic microsomes.
    Nakamura A; Tougou K; Kitazumi H; Yamada T; Honjou K; Zinno A; Nonaka K; Mukai H
    Arzneimittelforschung; 2005; 55(12):744-8. PubMed ID: 16430028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Equally potent inhibitors of cholesterol synthesis in human hepatocytes have distinguishable effects on different cytochrome P450 enzymes.
    Cohen LH; van Leeuwen RE; van Thiel GC; van Pelt JF; Yap SH
    Biopharm Drug Dispos; 2000 Dec; 21(9):353-64. PubMed ID: 11523064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.